{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:06:26Z","timestamp":1793862386850,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tjpad.2026.100502","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:00:49Z","timestamp":1770426049000},"page":"100502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer\u2019s disease neuroimaging initiative cohort"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-0769","authenticated-orcid":false,"given":"Kensaku","family":"Kasuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-841X","authenticated-orcid":false,"given":"Masataka","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9426-6804","authenticated-orcid":false,"given":"Emiko","family":"Kikkawa-Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7958-8991","authenticated-orcid":false,"given":"Tamao","family":"Tsukie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-4912","authenticated-orcid":false,"given":"Takanobu","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-8129","authenticated-orcid":false,"given":"Takeshi","family":"Iwatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-8085","authenticated-orcid":false,"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0001","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"18","key":"10.1016\/j.tjpad.2026.100502_bib0002","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","article-title":"Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape","volume":"111","author":"Hampel","year":"2023","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0003","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14397","article-title":"Plasma p-tau immunoassays in clinical research for Alzheimer's disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100502_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105405","article-title":"Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform","volume":"109","author":"Feizpour","year":"2024","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0006","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2022.1740","article-title":"Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers","volume":"79","author":"Janelidze","year":"2022","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100502_bib0007","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0008","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","volume":"5","author":"Ossenkoppele","year":"2025","journal-title":"Nat Aging"},{"issue":"15","key":"10.1016\/j.tjpad.2026.100502_bib0009","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100502_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated TAU 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0011","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100502_bib0012","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","article-title":"Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform","volume":"31","author":"Palmqvist","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0013","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jnnp-2025-335830","article-title":"Tailoring thresholds for interpreting plasma p-tau217 levels","volume":"96","author":"Ahn","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0014","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13195-025-01851-2","article-title":"Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Chang","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14502","article-title":"Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease","volume":"21","author":"Chong","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14297","article-title":"The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden","volume":"21","author":"Huang","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14526","article-title":"Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics","volume":"21","author":"Jang","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0018","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13195-025-01826-3","article-title":"Plasma phosphorylated tau 217 and amyloid\u2011beta 42\/40 for amyloid risk in subgroups","volume":"17","author":"Kang","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0019","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13195-025-01778-8","article-title":"Plasma biomarkers for early detection of alzheimer's disease: a cross-sectional study in a Japanese cohort","volume":"17","author":"Kubota","year":"2025","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0020","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s43587-025-00904-3","article-title":"Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population","volume":"5","author":"Lan","year":"2025","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100092","article-title":"Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimer's disease in a Chinese cohort","volume":"12","author":"Li","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14565","article-title":"Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea","volume":"21","author":"Lin","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma Abeta and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100502_bib0024","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1002\/alz.14138","article-title":"The Bayesian approach for real-world implementation of plasma p-tau217 in tertiary care memory clinics in Thailand","volume":"20","author":"Thanapornsangsuth","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100502_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70038","article-title":"Diagnostic accuracy of plasma p-tau217\/Abeta42 for Alzheimer's disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100502_bib0026","article-title":"Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: The Shanghai Aging Study","volume":"15","author":"Xiao","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100502_bib0027","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaneurol.2024.5263","article-title":"Temporal Dynamics and Biological Variability of Alzheimer Biomarkers","volume":"82","author":"Yun","year":"2025","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/Abeta1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: Insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14609","article-title":"A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic","volume":"21","author":"Anastasi","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14508","article-title":"The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study","volume":"21","author":"Ashton","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0031","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100502_bib0032","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1002\/alz.14140","article-title":"Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays","volume":"20","author":"Figdore","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100502_bib0033","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0034","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/awae368","article-title":"Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison","volume":"148","author":"Pilotto","year":"2025","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100502_bib0035","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0036","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/brain\/awae346","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","volume":"148","author":"Warmenhoven","year":"2025","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0037","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13195-024-01630-5","article-title":"Analytical and clinical performance of eight Simoa((R)) and Lumipulse((R)) assays for automated measurement of plasma p-tau181 and p-tau217","volume":"16","author":"Wojdala","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0038","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10020-019-0090-5","article-title":"A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease","volume":"25","author":"Asanomi","year":"2019","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0039","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tjpad.2026.100502_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnagi.2013.00017","article-title":"Pathology and pathogenesis of vascular cognitive impairment-a critical update","volume":"5","author":"Jellinger","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100502_bib0041","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jalz.2018.03.009","article-title":"Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials","volume":"14","author":"Iwatsubo","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100502_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2022-000321","article-title":"Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid","volume":"4","author":"Kasuga","year":"2022","journal-title":"BMJ Neurol Open"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100502_bib0043","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2016.11.007","article-title":"Recent publications from the Alzheimer's disease neuroimaging initiative: reviewing progress toward improved AD clinical trials","volume":"13","author":"Weiner","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0044","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-024-01414-x","article-title":"Polygenic effects on the risk of Alzheimer's disease in the Japanese population","volume":"16","author":"Kikuchi","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100502_bib0045","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210287","article-title":"Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations","volume":"104","author":"Bornhorst","year":"2025","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100502_bib0046","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","article-title":"Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios","volume":"80","author":"Janelidze","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14368","article-title":"Plasma Alzheimer's disease biomarker variability: amyloid-independent and amyloid-dependent factors","volume":"21","author":"Lee","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100502_bib0048","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100502_bib0049","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100502_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neurobiolaging.2023.03.007","article-title":"The clinical application of optimized AT(N) classification in Alzheimer's clinical syndrome (ACS) and non-ACS conditions","volume":"127","author":"Kasuga","year":"2023","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.tjpad.2026.100502_bib0051","series-title":"U.S. Food and Drug Administration","article-title":"FDA Clears First Blood Test Used in Diagnosing Alzheimer\u2019s Disease","year":"2025"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0052","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-020-00754-8","article-title":"Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's disease neuroimaging initiative","volume":"13","author":"Zettergren","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100502_bib0053","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100502_bib0054","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13195-022-00990-0","article-title":"Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients","volume":"14","author":"Pichet Binette","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100502_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70315","article-title":"Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease: A consecutive mixed memory clinic cohort study","volume":"21","author":"Kjaergaard","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100502_bib0056","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","article-title":"Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment","volume":"95","author":"Lehmann","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:52:08Z","timestamp":1776927128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2274580726000269"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100502","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer\u2019s disease neuroimaging initiative cohort","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100502"}}